Integrating Anti-SARS-CoV-2 Spike Protein IgG, IL-6, and NK Cell Percentage with Routine Laboratory Markers for COVID-19 Severity Assessment: Development and Validation of the CORIS Nomogram.

Yihe Zhang, Xuanming Xu, Lian Tang, Jiayue Ma, Yajie Wang

Abstract read

In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yihe ZhangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.ORCID 0009-0003-6469-8014

Xuanming XuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.ORCID 0009-0008-8617-471X

Lian TangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

Jiayue MaNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Yajie WangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.ORCID 0000-0002-3285-2537

Funding

Beijing Hospitals Authority's Ascent Plan DFL20241801Beijing Municipal Natural Science Foundation M21003National Key Research and Development Program of China 2022YFE0210400

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-SARS-CoV-2 spike protein IgGCOVID-19immune biomarkersinterleukin-6nomogramSARS-CoV-2

Identifiers

PMID42882288

DOI10.3390/diagnostics16193133

PMCPMC13664150

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.